Financial statements Medicofarma
Cash flow statement of Medicofarma
Company age:
Age:
18 y. 2 m. 9 d.
Share capital:
Share capital:
7 000 000 PLN
Cash inflows of MEDICOFARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 13 567 876,00 | -2 485 561,63 | 13 407 251,69 | -28 148,30 | 14 688 131,37 | 22 441 642,04 |
| Net cash flow from investing activities | -8 504 251,39 | -1 738 679,89 | -15 102 999,72 | -8 010 051,82 | -11 838 942,54 | -5 640 614,96 |
| Net cash flow from financial activities | -4 994 991,53 | 4 093 568,10 | 1 774 414,10 | 12 099 028,14 | -7 009 540,60 | -16 832 749,44 |
| Total net cash flow | 68 633,08 | -130 673,42 | 78 666,07 | 4 060 828,02 | -4 160 351,77 | -31 722,36 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.